Mega Lifesciences PCL
SET:MEGA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
TH |
|
D
|
Dave & Buster's Entertainment Inc
F:9DB
|
US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
US |
|
ASM International NV
AEX:ASM
|
NL |
|
Teva Pharmaceutical Industries Ltd
F:TEV
|
IL |
|
M
|
Masco Corp
XMUN:MSQ
|
US |
|
S
|
Standard Chartered PLC
F:STD
|
UK |
|
N
|
Novo Nordisk A/S
XMUN:NOVA
|
DK |
|
Societe BIC SA
PAR:BB
|
FR |
Wall St Price Targets
MEGA Price Targets Summary
Mega Lifesciences PCL
According to Wall Street analysts, the average 1-year price target for MEGA is 41.19 THB with a low forecast of 35.35 THB and a high forecast of 47.25 THB.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MEGA's stock price target?
Price Target
41.19
THB
According to Wall Street analysts, the average 1-year price target for MEGA is 41.19 THB with a low forecast of 35.35 THB and a high forecast of 47.25 THB.
What is the Revenue forecast for Mega Lifesciences PCL?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Mega Lifesciences PCL?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 5%.
What is the Net Income forecast for Mega Lifesciences PCL?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 11%.
